UK Authorizes World-First Gene Therapy from Vertex and CRISPR Therapeutics for Blood Disorders

November 16, 2023

Meitheal Announces Exclusive Commercial Licensing Agreement for Insulin Biosimilars in the US

October 18, 2023

Generic and Biosimilar Drugs Save $408B For America’s Patients and Healthcare System in 2022

September 15, 2023

HUMIRA (adalimumab) Biosimilar Launches

July 6, 2023

Updates on Recent Foreign Approvals and Launches

June 6, 2023

Alvotech and Advanz Pharma Extend Partnership to Commercialize Five Proposed Biosimilars in Europe

May 31, 2023

Bristol-Myers Squibb Files Patent Infringement Complaint Against AstraZeneca Regarding Anti-PD-L1 Antibody Product

May 1, 2023

Coya Announces Agreement with Dr. Reddy’s Laboratories for Treatment of Neurodegenerative Diseases

March 27, 2023

FDA Issues CRL for Biocon/Viatris Bevacizumab Biosimilar

February 24, 2023

Alvotech and Teva Announce Acceptance of BLA for AVT04, a Proposed Biosimilar to STELARA (ustekinumab)

January 13, 2023